|
Arjun P. Athreya, MS
FACTOR GRAPHS IDENTIFY SEX-SPECIFIC ANTIDEPRESSANT RESPONSE PROFILES: CITALOPRAM/ESCITALOPRAM AS MOLECULAR PROBES FOR SUBGROUPS OF MAJOR DEPRESSIVE DISORDER PATIENTS.
University of Illinois at Urbana-Champaign
View video |
| |
|
|
Kit Wun Kathy Cheung, PharmD
CHARACTERIZING THE ONTOGENY OF TEN RENAL TRANSPORTERS IN AFRICAN AMERICANS USING QUANTITATIVE PROTEOMICS, GENE EXPRESSION ANALYSIS, AND CLINICAL DATA.
University of California, San Francisco
View video |
| |
|
|
Rachel Dalton, PharmD
A MULTIFACTORIAL CYTOCHROME P450 2D6 GENOTYPE-PHENOTYPE PREDICTION APPROACH TO IMPROVE PRECISION OF CLINICAL PHARMACOGENETIC TEST INTERPRETATION.
University of Montana
View video |
| |
|
|
Jacqueline Gerhart, MS
PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING OF FLUCONAZOLE USING PLASMA AND CEREBROSPINAL FLUID SAMPLES COLLECTED FROM PRETERM AND TERM INFANTS.
UNC Eshelman School of Pharmacy
View video |
| |
|
|
Sophie Gravel, BSc
EFFECTS OF TYPE 2 DIABETES ON DUODENAL CYP450 ACTIVITIES.
University of Montreal – CRCHUM
View video |
| |
|
|
Ming-Fen Ho, PhD
KETAMINE AND KETAMINE METABOLITES AS NOVEL ESTROGEN RECEPTOR LIGANDS: INDUCTION OF CYP2A6, CYP2B6 AND AMPA RECEPTOR —GENOMIC LINKS TO SEX-DIFFERENCES IN KETAMINE RESPONSE.
Mayo Clinic
View video |
| |
|
|
Sarah Kim, PhD
APPLICATION OF A SYSTEMS PHARMACOLOGY APPROACH FOR A DETAILED INVESTIGATION OF AN ADVERSE DRUG REACTION DUE TO DISTINCT MECHANISMS OF IMMUNE CHECKPOINT INHIBITORS.
University of Florida
View video |
| |
|
|
Dea Kojovic, BSc
ELEVATED SFLT-1 IN PRE-ECLAMPSIA IS ASSOCIATED WITH A DOWNREGULATION OF TRANSPORTERS IN HUMAN PLACENTA.
University of Toronto
View video |
| |
|
|
Alix Leblanc, PhD
TARGETING OATP1B2 TO AMELIORATE PACLITAXEL-INDUCED CHRONIC PERIPHERAL NEUROPATHY.
The Ohio State University
View video |
| |
|
|
Stephanie Nicole Liu, PharmD
PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL INCORPORATING EXTRAHEPATIC GLUCURONIDATION PREDICTS INTEGRASE INHIBITOR PHARMACOKINETICS.
Indiana University School of Medicine
View video |
| |
|
|
Michael Martin, PharmD, PhD
TRANSLATIONAL MODEL OF PYRAZINAMIDE SITE-OF-ACTION PHARMACOKINETIC DISTRIBUTION IN A RABBIT MODEL OF TUBERCULOSIS AND IN TB PATIENTS.
University of California, San Francisco
View video |
| |
|
|
Rina Nishii, MS
PRECLINICAL EVALUATION OF NUDT15 GENOTYPE-GUIDED THIOPURINE DOSE INDIVIDUALIZATION USING CRISPR-CAS9 MOUSE MODEL.
St. Jude Children's Research Hospital
View video |
| |
|
|
Jagdeep T. Podichetty, PhD
IMPLEMENTING DATA MINING AND MACHINE LEARNING TECHNIQUES TO DRUG DEVELOPMENT IN SCHIZOPHRENIA.
Indiana University School of Medicine
View video |
| |
|
|
Sonal Singh, PhD
TARGETED SEQUENCING IDENTIFIES MISSENSE VARIANT IN THE BEST3 GENE ASSOCIATED WITH ANTIHYPERTENSIVE RESPONSE TO THIAZIDE DIURETICS.
University of Florida
View video |
| |
|
|
D. Max Smith, PharmD
OUTPATIENT CYP2D6 GENOTYPE-SUPPORTED OPIOID THERAPY: A PROSPECTIVE TRIAL.
University of Florida
View video |
| |
|
|
Ming-Liang Tan, PhD
PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING OF THE EFFECT OF CHRONIC KIDNEY DISEASE ON THE PHARMACOKINETICS OF NONRENALLY ELIMINATED DRUGS.
US Food and Drug Administration
View video |
| |
|
|
Tanaya Vaidya, MS
SYSTEMS PHARMACOLOGICAL ANALYSIS OF A TUMOR PRIMING COMBINATION THERAPY TO OVERCOME HER2 AND MTOR THERAPIES RESISTANCE IN BREAST CANCER.
University of Florida
View video |
| |
|
|
Ye Xiong, PhD
IMPROVED PREDICTION OF INFLIXIMAB CLEARANCE USING ERYTHROCYTE SEDIMENTATION RATE AND ANTI-INFLIXIMAB ANTIBODY LEVELS IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
Cincinnati Children's Hospital Medical Center
View video |
| |
|
|
Ling Zou, PhD
INTERACTIONS OF AZO DYES COMMONLY USED IN ORAL DRUG PRODUCTS WITH THE ORGANIC ANION TRANSPORTING PEPTIDE 2B1 AND HUMAN GUT BACTERIA.
University of California, San Francisco
View video |
| |
|